Skip to main content
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results for: March 9, 2011

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Pradaxa New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required
Veregan New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required
Latuda New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required
Kapvay New Drug Initial Review Require Prior Approval Prior Approval Required
Fanapt New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required
Pegasys PDL Appeal Remove Prior Approval Requirement Prior Approval Requirement Removed